NLS Saniona

Pharma Business - August 31, 2021

Saniona receives Orphan Drug Designation

Saniona announced July 26th that the U.S. Food and Drug Administration had granted orphan drug designation to Tesomet for the treatment of hypothalamic obesity (HO). Tesomet is the first and only investigational treatment for HO to receive orphan drug designation, the company states. Saniona is preparing to initiate two Phase 2b studies of Tesomet in […]

Clinical Trials - April 22, 2020

Positive trial results from Saniona

Saniona has announced results from its 24-week double blind, randomized, placebo-controlled Phase 2 trial evaluating the safety and efficacy of Tesomet in patients with hypothalamic obesity (HO). The study results showed that Tesomet was safe and well tolerated. Furthermore, efficacy data was also reported, with statistically significant improvements in body weight, waist circumference, and glycemic […]

Agreement - August 29, 2016

Saniona, Boehringer Ingelheim in agreement

Boehringer Ingelheim and Saniona, a Nordic biotech company in the field of ion channel drug discovery, today announced that they have entered into a research collaboration with the objective to discover and develop novel compounds for the treatment of schizophrenia. Saniona may receive up to €90 million in milestone payments including an upfront payment of […]

Clinical Trials - June 13, 2016

Saniona initiates Phase 2a study

Saniona, a biotech company in the field of ion channels, has announced that the University of Pennsylvania Treatment Research Center (TRC) has initiated recruitment of patients in a Phase 2a study for their compound, NS2359, for treatment of cocaine addiction. Today there are no approved drugs to treat cocaine addiction. The trial comprises a total of up […]

Agreement - February 26, 2014

Saniona collaborates with Pfizer in million dollar agreement

The Danish biotechnology company has announced a drug developement collaboration with the global pharma giant. Saniona, previously known under the name Aniona, focuses on small molecule drug discovery within the ion channel field. The collaboration with Pfizer involves research on pharmaceuticals to treat neurological diseases and makes use of Saniona’s expertise within the ion channel field, […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.